Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03734588
Recruitment Status : Recruiting
First Posted : November 8, 2018
Last Update Posted : March 13, 2019
Sponsor:
Information provided by (Responsible Party):
Spark Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 2020
  Estimated Study Completion Date : April 2020